authors
- Kyriakopoulos, C
- Chatta, G
- Laccetti, AL
- Iannotti, N
- Sokolova, AO
- Hotte, Sebastien
- Tutrone, R
- Markowski, MC
- Nordquist, LT
- Pili, R
- Saad, F
- Zhang, J
- Villaluna, K
- Younginger, B
- Le Moigne, R
- Cesano, A
Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2024
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal